An analysis of past research conducted by the Salt Lake City-based University of Utah Health John A. Moran Eye Center found cause for further testing to determine if cataracts might someday be ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The phase 3 OPTIMIZE trial met both primary efficacy ...

Credit: Getty Images. OCS-01 is a novel, high concentration (15mg/mL), topical formulation of dexamethasone. Once-daily administration of an investigational corticosteroid eye drop (OCS-01) was found ...

Please provide your email address to receive an email when new articles are posted on . A novel preservative-free betamethasone eye drop formulation showed efficacy in preventing inflammation and pain ...

ZUG, Switzerland, and BOSTON, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, ...

Dr. Katie Mills captures this perspective neatly: “At Loden Vision Centers, LASIK and cataract surgery are discussed together ...

One of the most common conversations in an eye clinic starts something like this: “My sister has just had her cataracts done.

Steven Reed, OD, is a board-certified optometrist and president of the American Optometric Association. With over 25 years of experience, Dr. Reed has also served as past president of the Mississippi ...

An expert MD reveals clear insights into cataract surgery, spotlighting the breakthroughs in treatment: "We live in a time of miracle and wonder." Cataracts are a common eye condition that affects ...

OPTIMIZE (Once-daily Post-ocular surgery Treatment for InflaMmation and paIn to minimiZE drops) is a double-blind, placebo-controlled Phase 3 trial conducted in 25 sites across the US with 241 ...